scispace - formally typeset
B

Bernard Fritzell

Researcher at Pfizer

Publications -  27
Citations -  1399

Bernard Fritzell is an academic researcher from Pfizer. The author has contributed to research in topics: Pneumococcal conjugate vaccine & Conjugate vaccine. The author has an hindex of 21, co-authored 27 publications receiving 1377 citations.

Papers
More filters
Journal ArticleDOI

Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.

TL;DR: Implementation of PCV7, combined with a reduction in antibiotic use, in a country with a high prevalence of antibiotic-resistant pneumococci appears to have a strong impact on the carriage of penicillin nonsusceptible pneumitis in children with AOM.
Journal ArticleDOI

The relationship between pneumococcal serotypes and antibiotic resistance.

TL;DR: Changing trends in antibiotic resistance and serotype distribution during this time, including those before and after the introduction of 7-valent pneumococcal conjugate vaccine (PCV7), were analyzed.
Journal ArticleDOI

The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age.

TL;DR: The only adverse systemic reaction attributable to PRP-T beyond that caused by DTP alone was a 7 to 20% increase in febrile responses in the first 24 hours after the first and second doses of vaccine; the fevers were largely low grade and not accompanied by increased irritability, diminished activity or loss of appetite.
Journal ArticleDOI

Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy.

TL;DR: Serotype-specific hyporesponsiveness to PCV7 after pneumococcal carriage in infants is demonstrated for the first time and was only partially overcome by the 12-month booster.
Journal ArticleDOI

Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine.

TL;DR: Concurrent administration of PRP-T vaccine with DTP vaccine, either in the same syringe or at different sites, interfered with antipertussis responses to a primary series of immunizations, and the clinical significance of this antagonism is uncertain.